Hetzer Medical Indonesia Tbk. vs Saraswanti Indoland Development Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp82 (market cap 126.56B, 319.74M 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp91 (market cap 500.81B, 1.26M 24h volume). The key difference: Saraswanti Indoland Development Tbk. is far larger — about 4× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (319.74M versus 1.26M). Which is the better fit depends on your goals.
| MEDS | SWID | |
|---|---|---|
Market Cap | 126.56B | 500.81B |
Volume | 319.74M | 1.26M |
Lot | 3.2M | 12.61K |
Turnover | 27.4B | 113.99M |
Average Price | 85.68 | 90.38 |
Value | 27.4B | 113.99M |
Indicative Equilibrium Price | 82 | 91 |
Indicative Equilibrium Volume | 12.79K | 643 |
Trailing returns across standard periods
Latest headlines on both assets
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →